 |
|
Further Studies of the Effect of Vitamin D on RetinoblastomaInhibition With 1,25-Dihydroxycholecalciferol
Steven M. Cohen;
Amanda M. Saulenas;
Catherine R. Sullivan;
Daniel M. Albert, MD
Arch Ophthalmol. 1988;106(4):541-543.
Abstract
• We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.
Author Affiliations
From the Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston.
Footnotes
Accepted for publication Oct 30, 1987.
Reprint requests to Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114 (Dr Albert).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Calcitriol Is a Potent Inhibitor of Retinal Neovascularization
Albert et al.
IOVS 2007;48:2327-2334.
ABSTRACT
| FULL TEXT
Effectiveness of Vitamin D Analogues in Treating Large Tumors and During Prolonged Use in Murine Retinoblastoma Models
Albert et al.
Arch Ophthalmol 2004;122:1357-1362.
ABSTRACT
| FULL TEXT
Toxicity and Dose-Response Studies of 1{alpha}-Hydroxyvitamin D2 in a Retinoblastoma Xenograft Model
Grostern et al.
Arch Ophthalmol 2002;120:607-612.
ABSTRACT
| FULL TEXT
Antineoplastic Effect of 1,25-Dihydroxy-16-ene-23-yne-Vitamin D3 Analogue in Transgenic Mice With Retinoblastoma
Shternfeld et al.
Arch Ophthalmol 1996;114:1396-1401.
ABSTRACT
|
